Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 39

1.

Shaker-related voltage-gated potassium channels Kv1 in human hippocampus.

Willis M, Leitner I, Seppi K, Trieb M, Wietzorrek G, Marksteiner J, Knaus HG.

Brain Struct Funct. 2018 Jul;223(6):2663-2671. doi: 10.1007/s00429-018-1653-x. Epub 2018 Mar 21.

PMID:
29564531
2.
3.

Diagnostic and prognostic accuracy of galectin-3 and soluble ST2 for acute heart failure.

Mueller T, Gegenhuber A, Leitner I, Poelz W, Haltmayer M, Dieplinger B.

Clin Chim Acta. 2016 Dec 1;463:158-164. doi: 10.1016/j.cca.2016.10.034. Epub 2016 Oct 29.

4.

Small-conductance calcium-activated potassium type 2 channels (SK2, KCa2.2) in human brain.

Willis M, Trieb M, Leitner I, Wietzorrek G, Marksteiner J, Knaus HG.

Brain Struct Funct. 2017 Mar;222(2):973-979. doi: 10.1007/s00429-016-1258-1. Epub 2016 Jun 29.

5.

Interleukin 6, galectin 3, growth differentiation factor 15, and soluble ST2 for mortality prediction in critically ill patients.

Dieplinger B, Egger M, Leitner I, Firlinger F, Poelz W, Lenz K, Haltmayer M, Mueller T.

J Crit Care. 2016 Aug;34:38-45. doi: 10.1016/j.jcrc.2016.03.020. Epub 2016 Mar 30.

6.

Reference values of galectin-3 and cardiac troponins derived from a single cohort of healthy blood donors.

Mueller T, Egger M, Leitner I, Gabriel C, Haltmayer M, Dieplinger B.

Clin Chim Acta. 2016 May 1;456:19-23. doi: 10.1016/j.cca.2016.02.014. Epub 2016 Feb 24.

7.

Plasma concentrations of novel cardiac biomarkers before and after hemodialysis session.

Mueller T, Gegenhuber A, Kronabethleitner G, Leitner I, Haltmayer M, Dieplinger B.

Clin Biochem. 2015 Nov;48(16-17):1163-6. doi: 10.1016/j.clinbiochem.2015.07.031. Epub 2015 Jul 29.

8.

The single nucleotide polymorphism Gly482Ser in the PGC-1α gene impairs exercise-induced slow-twitch muscle fibre transformation in humans.

Steinbacher P, Feichtinger RG, Kedenko L, Kedenko I, Reinhardt S, Schönauer AL, Leitner I, Sänger AM, Stoiber W, Kofler B, Förster H, Paulweber B, Ring-Dimitriou S.

PLoS One. 2015 Apr 17;10(4):e0123881. doi: 10.1371/journal.pone.0123881. eCollection 2015.

9.

Association of the biomarkers soluble ST2, galectin-3 and growth-differentiation factor-15 with heart failure and other non-cardiac diseases.

Mueller T, Leitner I, Egger M, Haltmayer M, Dieplinger B.

Clin Chim Acta. 2015 May 20;445:155-60. doi: 10.1016/j.cca.2015.03.033. Epub 2015 Apr 4.

10.

Chromogranin peptides in brain diseases.

Willis M, Leitner I, Jellinger KA, Marksteiner J.

J Neural Transm (Vienna). 2011 May;118(5):727-35. doi: 10.1007/s00702-011-0648-z. Epub 2011 Apr 30. Review.

PMID:
21533607
11.

The third-generation P-glycoprotein inhibitor tariquidar may overcome bacterial multidrug resistance by increasing intracellular drug concentration.

Leitner I, Nemeth J, Feurstein T, Abrahim A, Matzneller P, Lagler H, Erker T, Langer O, Zeitlinger M.

J Antimicrob Chemother. 2011 Apr;66(4):834-9. doi: 10.1093/jac/dkq526. Epub 2011 Jan 19.

PMID:
21393173
12.

Plasma protein binding of fluoroquinolones affects antimicrobial activity.

Zeitlinger M, Sauermann R, Fille M, Hausdorfer J, Leitner I, Müller M.

J Antimicrob Chemother. 2008 Mar;61(3):561-7. doi: 10.1093/jac/dkm524. Epub 2008 Jan 23.

PMID:
18216178
13.

Clinical scoring system for the prediction of target site penetration of antimicrobials in patients with sepsis.

Zeitlinger BS, Zeitlinger M, Leitner I, Müller M, Joukhadar C.

Clin Pharmacokinet. 2007;46(1):75-83.

PMID:
17201459
14.

Biological, biochemical, and molecular characterization of a new clinical Trichophyton rubrum isolate resistant to terbinafine.

Osborne CS, Leitner I, Hofbauer B, Fielding CA, Favre B, Ryder NS.

Antimicrob Agents Chemother. 2006 Jun;50(6):2234-6.

15.

Amino acid substitution in Trichophyton rubrum squalene epoxidase associated with resistance to terbinafine.

Osborne CS, Leitner I, Favre B, Ryder NS.

Antimicrob Agents Chemother. 2005 Jul;49(7):2840-4.

16.

No association of clock gene T3111C polymorphism and affective disorders.

Bailer U, Wiesegger G, Leisch F, Fuchs K, Leitner I, Letmaier M, Konstantinidis A, Stastny J, Sieghart W, Hornik K, Mitterauer B, Kasper S, Aschauer HN.

Eur Neuropsychopharmacol. 2005 Jan;15(1):51-5.

PMID:
15572273
17.

Antifungal drug response in an in vitro model of dermatophyte nail infection.

Osborne CS, Leitner I, Favre B, Ryder NS.

Med Mycol. 2004 Apr;42(2):159-63.

PMID:
15124869
18.

Quetiapine in a delusional depressed elderly patient: no EPS and a favourable outcome.

Leitner I, Praschak-Rieder N, Willeit M, Kasper S.

Int J Neuropsychopharmacol. 2003 Jun;6(2):199-200. No abstract available.

PMID:
12890313
19.

Clinical Trichophyton rubrum strain exhibiting primary resistance to terbinafine.

Mukherjee PK, Leidich SD, Isham N, Leitner I, Ryder NS, Ghannoum MA.

Antimicrob Agents Chemother. 2003 Jan;47(1):82-6.

21.

[Depressive pseudodementia].

Fischer P, Bailer U, Hilger E, Leitner I.

Wien Med Wochenschr. 2002;152(3-4):62-5. German.

PMID:
11925773
22.
23.

In vitro activities of terbinafine against cutaneous isolates of Candida albicans and other pathogenic yeasts.

Ryder NS, Wagner S, Leitner I.

Antimicrob Agents Chemother. 1998 May;42(5):1057-61.

24.
25.

Synthesis and structure-activity relationships of the novel homopropargylamine antimycotics.

Nussbaumer P, Leitner I, Stütz A.

J Med Chem. 1994 Mar 4;37(5):610-5.

PMID:
8126700
26.
27.

Synthesis and structure-activity relationships of naphthalene-substituted derivatives of the allylamine antimycotic terbinafine.

Nussbaumer P, Dorfstätter G, Leitner I, Mraz K, Vyplel H, Stütz A.

J Med Chem. 1993 Sep 17;36(19):2810-6.

PMID:
8410994
28.

Synthesis and structure-activity relationships of phenyl-substituted benzylamine antimycotics: a novel benzylbenzylamine antifungal agent for systemic treatment.

Nussbaumer P, Dorfstätter G, Grassberger MA, Leitner I, Meingassner JG, Thirring K, Stütz A.

J Med Chem. 1993 Jul 23;36(15):2115-20.

PMID:
8340915
29.

Activation of an inducible c-FosER fusion protein causes loss of epithelial polarity and triggers epithelial-fibroblastoid cell conversion.

Reichmann E, Schwarz H, Deiner EM, Leitner I, Eilers M, Berger J, Busslinger M, Beug H.

Cell. 1992 Dec 24;71(7):1103-16.

PMID:
1473147
30.

Transcriptional repression of band 3 and CAII in v-erbA transformed erythroblasts accounts for an important part of the leukaemic phenotype.

Fuerstenberg S, Leitner I, Schroeder C, Schwarz H, Vennström B, Beug H.

EMBO J. 1992 Sep;11(9):3355-65.

31.
32.

Mastomys natalensis as an experimental host for Brugia malaye subperiodic.

Petrányi G, Mieth H, Leitner I.

Southeast Asian J Trop Med Public Health. 1975 Sep;6(3):328-37.

PMID:
1221502
33.

[The position of the mentally ill patient in general practice].

Leitner I.

Munch Med Wochenschr. 1970 Oct 30;112(44):2003-6. German. No abstract available.

PMID:
5536869
34.

[Sociopsychiatric consequences of an acute economic crisis].

Strotzka H, Leitner I.

Wien Med Wochenschr. 1969 Mar 8;119(10):196-9. German. No abstract available.

PMID:
5769288
35.
36.

[Observations on the treatment of hypertension in general practice].

Leitner I.

Landarzt. 1965 May 20;41(17):725-7. German. No abstract available.

PMID:
5825247
37.

[ON A SYSTEMATIC PATTERN FOR THE CASES IN GENERAL PRACTICE].

BRAUN RN, FREITAG A, BUCHMAYER E, LEITNER I.

Munch Med Wochenschr. 1964 Sep 18;106:1660-2. German. No abstract available.

PMID:
14311964
38.

[WORK TIME ANALYSIS IN MEDICAL PRACTICE FROM THE STANDPOINT OF SOCIAL PSYCHIATRY].

STROTZKA H, LEITNER I.

Wien Med Wochenschr. 1964 Jun 13;114:421-4. German. No abstract available.

PMID:
14241479
39.

[On the ratio of mental patients in the intake of the general practitioner].

LEITNER I.

Med Welt. 1961 Aug 26;34:1701-3. German. No abstract available.

PMID:
13760621

Supplemental Content

Loading ...
Support Center